can i take glp 1 if i have hypothyroidism Weight Loss with Hypothyroidism: GLP-1 Safety Guide GLP-1 Therapy with Thyroid Conditions

Kentucky Medicaid coverage for obesity medications is more limited but has been expanding

The shares are up roughly 30% year-to-date, compared to a rise of 6.9% for the S&P 500 Index ($SPX)

Carbs are not the enemy

Researchers found that the participants who took tirzepatide lost at least 15% more body weight after 12 months than those who took semaglutide

A recent human study presented at the Endocrine Society meeting found that obese men treated with GLP1 receptor agonists, including semaglutide, dulaglutide or tirzepatide, experienced a rise in normal testosterone levels from 53 percent to 77 percent over 18 months (closely correlated with weight loss), demonstrating how peptide-based therapies can effectively support and restore healthy testosterone production